Elevate Capital Innovation Gap Fund: Oregon's First Commercialization Gap Fund to Support Science and Invention Based Startups

×

Error message

  • Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).

PORTLAND, Ore., Oct. 25, 2021 /PRNewswire/ -- Elevate Capital , Oregon's first inclusive venture capital fund that supports inclusion and diversity was proud to manage Business Oregon's first Commercialization Gap Fund , "the Gap Fund," a $2.5 million fund created to invest in early-stage, science-based Oregon-based startups.

Metadata
Provider: 
PR NewswirePR Newswire
Retrieved on: 
Monday, October 25, 2021
Information
Tags: 
Woman, Veteran, Capital, Research, Oregon Business Development Department, Immunotherapy, Efficiency, LinkedIn, Vaccine, State, VAP, Elevate Capital, Twitter, Patient, View, Color, Technology, CPAP, Investment, Multimedia, Nervous system, Therapy, Temperature, LeapFrog Enterprises, Ventilator-associated pneumonia, Fund, AI, Mouth, Financial services, Cryptocurrency, Pharmaceutical industry
Geotags: 
Oregon, ORE
Organisation: 
ELEVATE CAPITAL
Summary
Key Points: 
  • PORTLAND, Ore., Oct. 25, 2021 /PRNewswire/ -- Elevate Capital , Oregon's first inclusive venture capital fund that supports inclusion and diversity was proud to manage Business Oregon's first Commercialization Gap Fund , "the Gap Fund," a $2.5 million fund created to invest in early-stage, science-based Oregon-based startups.
  • Through Elevate Capital's work with the Gap Fund, the process has exposed a dire need for capital for Oregon's early-stage companies coming out of its research institutions.
  • Elevate Capital's support and management of the Commercialization Gap Fund have been integral to helping companies continue to raise additional funding.
  • Elevate Capital achieved all this despite the Gap Fund nearly disappearing due to the COVID-19-pandemic-induced economic downturn.


Elevate Capital Innovation Gap Fund: Oregon's First Commercialization Gap Fund to Support Science and Invention Based Startups

PORTLAND, Ore., Oct. 25, 2021 /PRNewswire/ -- Elevate Capital, Oregon's first inclusive venture capital fund that supports inclusion and diversity was proud to manage Business Oregon's first Commercialization Gap Fund, "the Gap Fund," a $2.5 million fund created to invest in early-stage, science-based Oregon-based startups. Through this Fund, $1.75 million has already been invested.

We discovered how much innovation is being left on the table as these companies are underserved and starved for capital.

The Fund made 15 investments in 12 months, with check sizes varying from $50,000 to $250,000—supporting key points in business development and providing companies with the capital to hit their technology milestones. Of these startup companies, one-third are led by women, and 27% have minority or immigrant founders.

Through Elevate Capital's work with the Gap Fund, the process has exposed a dire need for capital for Oregon's early-stage companies coming out of its research institutions.

"What we discovered in this process is how much innovation is being left on the table as these companies are underserved and starved for capital," said Nitin Rai, Founder and Managing Partner at Elevate Capital. Elevate Capital will be reapplying to be the fund manager of the Business Oregon fund for the 2021-2023 biennium to continue working towards funding these underserved entrepreneurs and their innovative ideas."

Gap Fund Companies Raise Additional Outside Investments and Grant Funding

Elevate Capital's support and management of the Commercialization Gap Fund have been integral to helping companies continue to raise additional funding. Gap Fund companies have gone on to raise over $4 million in outside investments and $4.5 million in grant funding.

Elevate Capital achieved all this despite the Gap Fund nearly disappearing due to the COVID-19-pandemic-induced economic downturn.

Elevate Capital leveraged its internal resources and built a compelling pipeline of candidates in collaboration with the State's Signature Research Centers and academic institutions. This funding has proved integral to the early success of the companies listed below: 

  • biomotum is developing a soft robotic exoskeleton to improve walking function in patients with mobility impairments.
  • CytoImage uses high-throughput single-cell functional screening for individualized, target immunotherapy.
  • HOLO Footwear is creating a "sustainable and attainable" footwear brand using 100% recycled material and targeting diverse demographics.
  • LeapFrog Design has miniaturized wetland to a container size that can efficiently clean and recycle household greywater while adding aesthetic value to the home.
  • LifeAir is pioneering a new, disposable ventilator to reduce or eliminate ventilator-associated pneumonia (VAP).
  • Magwire is enabling the next generation of flexible electronics using Transparent Conductive Films (TCFs).
  • NeuroBiome is developing an organ onto a chip to replicate the connection between the gut and the nervous system.
  • ProMedix is developing a point of care sensor to diagnose and monitor sepsis.
  • ReNewCat is developing a new process for efficiently creating plant-based oleofuran surfactants.
  • Rewire Neuro is using AI and computer vision to improve the speed, accuracy, and precision of digital pathology.
  • Skip Technology is developing a novel chemical flow battery to improve both electrical and economic efficiency of large-scale battery storage.
  • SomnoSeal device is an oral sealing device to prevent mouth leaking while using a nasal CPAP, improving overall treatment success.
  • Stonestable is developing a silica-based cage that will help make vaccines stable at room temperature.
  • Veana Therapeutics is developing effective cancer immunotherapies using its proprietary VIMO compound.
  • VitalFlo helps leading clinicians and researchers improve patient outcomes and advance lung health by providing comprehensive respiratory data, analysis, and care.

About Elevate Capital

Elevate Capital is a Pacific Northwest-based venture capital firm that invests nationally in early-stage underrepresented entrepreneurs, that includes women, people of color, LGBTQ+, and veterans. Visit elevate.vc or follow Elevate Capital on Twitter, Facebook, and LinkedIn.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/elevate-capital-innovation-gap-fund-oregons-first-commercialization-gap-fund-to-support-science-and-invention-based-startups-301407452.html

SOURCE Elevate Capital

Copyright: 
2021 PR Newswire. All Rights Reserved.